Brighton Jones LLC decreased its holdings in CVS Health Co. (NYSE:CVS – Free Report) by 7.0% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 9,775 shares of the pharmacy operator’s stock after selling 735 shares during the period. Brighton Jones LLC’s holdings in CVS Health were worth $577,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds also recently bought and sold shares of the company. Ables Iannone Moore & Associates Inc. bought a new stake in CVS Health during the fourth quarter valued at about $32,000. Creekmur Asset Management LLC bought a new stake in shares of CVS Health in the 4th quarter valued at about $34,000. Steph & Co. grew its position in shares of CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after buying an additional 288 shares during the last quarter. Kapitalo Investimentos Ltda purchased a new stake in CVS Health during the fourth quarter valued at approximately $36,000. Finally, Scarborough Advisors LLC acquired a new stake in CVS Health in the fourth quarter valued at approximately $37,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.
CVS Health Trading Down 1.5 %
Shares of NYSE:CVS opened at $57.51 on Friday. The company has a market capitalization of $72.20 billion, a PE ratio of 10.11, a PEG ratio of 0.79 and a beta of 0.53. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The business has a 50 day moving average of $58.31 and a two-hundred day moving average of $62.52. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83.
CVS Health Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be issued a $0.665 dividend. The ex-dividend date is Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 4.63%. CVS Health’s payout ratio is 46.75%.
Analyst Ratings Changes
Several brokerages have recently commented on CVS. Wells Fargo & Company increased their price objective on CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a report on Monday, August 12th. Robert W. Baird began coverage on CVS Health in a research note on Thursday, May 30th. They issued a “neutral” rating and a $61.00 price target for the company. Cantor Fitzgerald restated a “neutral” rating and set a $62.00 price objective on shares of CVS Health in a report on Monday, September 16th. Baird R W upgraded shares of CVS Health to a “hold” rating in a research note on Thursday, May 30th. Finally, Evercore ISI cut their price target on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating on the stock in a research note on Thursday, August 8th. Eleven analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to data from MarketBeat.com, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $72.10.
Get Our Latest Analysis on CVS Health
CVS Health Profile
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Read More
- Five stocks we like better than CVS Health
- Why Are Stock Sectors Important to Successful Investing?
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- MarketBeat Week in Review – 9/16 – 9/20
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Don’t Miss These 3 Retail Stocks for Fall Gains
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.